However, it was also reported that GSK3β inhibition could decrease proliferation of rapamycin-insensitive breast cancer cells, suggesting that GSK3β can modulate cell proliferation by both S6K1-dependent and -independent mechanisms [110]. This evidence concerns the gene RPS6KB1 and breast cancer.